We thus excluded patients without survival time, event status, age, tumor size, grade, stage, lymph node status, PAM50 subtypes, ER-status, HER2 status, chemotherapy, radiotherapy, or hormone therapy information. This evidence concerns the gene ERBB2 and neoplasm.